(Q36428532)

14 August 2017

1 reference

title

Treatment of gastroparesis: a multidisciplinary clinical review (English)

1 reference

14 August 2017

1 reference

Abell TL

1

1 reference

14 August 2017

Bernstein RK

2

1 reference

14 August 2017

Cutts T

3

1 reference

14 August 2017

Farrugia G

4

1 reference

14 August 2017

Forster J

5

1 reference

14 August 2017

Hasler WL

6

1 reference

14 August 2017

McCallum RW

7

1 reference

14 August 2017

Olden KW

8

1 reference

14 August 2017

Parkman HP

9

1 reference

14 August 2017

Parrish CR

10

1 reference

14 August 2017

Pasricha PJ

11

1 reference

14 August 2017

Prather CM

12

1 reference

14 August 2017

Soffer EE

13

1 reference

14 August 2017

Twillman R

14

1 reference

14 August 2017

Vinik AI

15

1 reference

14 August 2017

1 April 2006

1 reference

Neurogastroenterology and Motility

14 August 2017

1 reference

14 August 2017

18

1 reference

14 August 2017

4

1 reference

14 August 2017

263-283

1 reference

American Gastroenterological Association technical review on the diagnosis and treatment of gastroparesis

14 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00760.X

Demography, clinical characteristics, psychological and abuse profiles, treatment, and long-term follow-up of patients with gastroparesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00760.X

American gastroenterological association technical review on the evaluation of dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00760.X

Risk indicators of delayed gastric emptying of solids in patients with functional dyspepsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00760.X

Development and validation of a patient-assessed gastroparesis symptom severity measure: the Gastroparesis Cardinal Symptom Index.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00760.X

Prokinetics in patients with gastroparesis: a systematic analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00760.X

Metoclopramide to treat gastroparesis due to diabetes mellitus: a double-blind, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00760.X

The prevalence of metoclopramide-induced tardive dyskinesia and acute extrapyramidal movement disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00760.X

Tardive dyskinesia risks and metoclopramide use before and after U.S. market withdrawal of cisapride

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00760.X

Domperidone in the management of symptoms of diabetic gastroparesis: efficacy, tolerability, and quality-of-life outcomes in a multicenter controlled trial. DOM-USA-5 Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00760.X

Effect of chronic oral domperidone therapy on gastrointestinal symptoms and gastric emptying in patients with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00760.X

The effect of intravenous erythromycin on solid meal gastric emptying in patients with chronic symptomatic post-vagotomy-antrectomy gastroparesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00760.X

Erythromycin inhibits rabbit pyloric smooth muscle through neuronal motilin receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00760.X

Oral erythromycin and symptomatic relief of gastroparesis: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00760.X

Oral erythromycin and the risk of sudden death from cardiac causes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00760.X

Failure of a motilin receptor agonist (ABT-229) to relieve the symptoms of functional dyspepsia in patients with and without delayed gastric emptying: a randomized double-blind placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00760.X

Effects of a motilin receptor agonist (ABT-229) on upper gastrointestinal symptoms in type 1 diabetes mellitus: a randomised, double blind, placebo controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00760.X

Ghrelin enhances gastric emptying in diabetic gastroparesis: a double blind, placebo controlled, crossover study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00760.X

Influence of ghrelin on gastric emptying and meal-related symptoms in idiopathic gastroparesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00760.X

Long-term cisapride treatment improves diabetic gastroparesis but not glycaemic control

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00760.X

Long-term efficacy of oral cisapride in symptomatic upper gut dysmotility.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00760.X

Access options for withdrawn motility-modifying agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00760.X

Tegaserod, a 5-HT4 receptor partial agonist, accelerates gastric emptying and gastrointestinal transit in healthy male subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00760.X

Tegaserod, a 5-hydroxytryptamine type 4 receptor partial agonist, is devoid of electrocardiographic effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00760.X

Effect of mosapride on glycemic control and gastric emptying in type 2 diabetes mellitus patients with gastropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00760.X

Effects of KW-5092 on antroduodenal coordination and gastric emptying in guinea-pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00760.X

Acute effect of clonidine on gastric emptying in patients with diabetic gastropathy and controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00760.X

The efficacy and safety of transdermal scopolamine for the prevention of postoperative nausea and vomiting: a quantitative systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00760.X

Dimenhydrinate for prophylaxis of postoperative nausea and vomiting: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00760.X

Antiemetic efficacy of prophylactic dimenhydrinate (Dramamine) vs ondansetron (Zofran): a randomized, prospective trial inpatients undergoing laparoscopic cholecystectomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00760.X

Does intravenous ondansetron affect gastric emptying of a solid meal, gastric electrical activity or blood hormone levels in healthy volunteers?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00760.X

Effects of the 5-HT3 receptor antagonist ICS 205-930 on fat-delayed gastric emptying and antral motor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00760.X

Aprepitant: a review of its use in the prevention of chemotherapy-induced nausea and vomiting

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00760.X

Antiemetic activity of the NK1 receptor antagonist GR205171 in the treatment of established postoperative nausea and vomiting after major gynaecological surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00760.X

Tricyclic antidepressants for functional nausea and vomiting: clinical outcome in 37 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00760.X

Ginger reduces hyperglycemia-evoked gastric dysrhythmias in healthy humans: possible role of endogenous prostaglandins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00760.X

The efficacy of acupressure and acustimulation wrist bands for the relief of chemotherapy-induced nausea and vomiting. A University of Rochester Cancer Center Community Clinical Oncology Program multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00760.X

Duloxetine vs. placebo in patients with painful diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00760.X

Selective effects of serotonergic psychoactive agents on gastrointestinal functions in health

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00760.X

Role of topiramate for the treatment of painful diabetic peripheral neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00760.X

Towards identifying optimal doses for alpha-2 adrenergic modulation of colonic and rectal motor and sensory function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00760.X

Low-dose oral naloxone reverses opioid-induced constipation and analgesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00760.X

A review of the potential role of methylnaltrexone in opioid bowel dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00760.X

Effect of alvimopan and codeine on gastrointestinal transit: a randomized controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00760.X

Impact of functional dyspepsia on quality of life.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00760.X

Symptom improvement from prokinetic therapy corresponds to improved quality of life in patients with severe dyspepsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00760.X

Sexual and physical abuse and gastrointestinal illness. Review and recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00760.X

Is gastric electrical stimulation superior to standard pharmacologic therapy in improving GI symptoms, healthcare resources, and long-term health care benefits?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00760.X

Prevalence of gastrointestinal symptoms associated with diabetes mellitus: a population-based survey of 15,000 adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00760.X

Gastrointestinal tract symptoms among persons with diabetes mellitus in the community.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00760.X

Hyperglycemia induces abnormalities of gastric myoelectrical activity in patients with type I diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00760.X

Glucose control is not improved by accelerating gastric emptying in patients with type 1 diabetes mellitus and gastroparesis. a pilot study with cisapride as a model drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00760.X

Pilot study on gastric electrical stimulation on surgery-associated gastroparesis: long-term outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00760.X

Clinical response to gastric electrical stimulation in patients with postsurgical gastroparesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00760.X

Temporary gastric electrical stimulation with orally or PEG-placed electrodes in patients with drug refractory gastroparesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00760.X

Long-term outcome after gastrectomy for intractable diabetic gastroparesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00760.X

Completion gastrectomy for refractory gastroparesis following surgery for peptic ulcer disease. Long-term follow-up with subjective and objective parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2006.00760.X

10.1111/J.1365-2982.2006.00760.X

21 January 2018

Identifiers

DOI

1 reference

release_73iiv5bc5baodhacgtus76piu4

14 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/73iiv5bc5baodhacgtus76piu4

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference